FDA Efforts to Advance Medical Product Development for Rare Diseases
Celia Witten · Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Celia Witten · Center for Biologics Evaluation and Research, U.S. Food and Drug Administration